BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21856747)

  • 21. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC; Astapova I; Hollenberg AN; Balk SP
    Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer.
    Schiewer MJ; Morey LM; Burd CJ; Liu Y; Merry DE; Ho SM; Knudsen KE
    Oncogene; 2009 Feb; 28(7):1016-27. PubMed ID: 19079343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.
    Kikuchi M; Okumura F; Tsukiyama T; Watanabe M; Miyajima N; Tanaka J; Imamura M; Hatakeyama S
    Biochim Biophys Acta; 2009 Dec; 1793(12):1828-36. PubMed ID: 19909775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.
    Kim Y; Kim J; Jang SW; Ko J
    Oncogene; 2015 Jan; 34(2):226-36. PubMed ID: 24441043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.
    Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA
    Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells.
    Yang X; Guo Z; Sun F; Li W; Alfano A; Shimelis H; Chen M; Brodie AMH; Chen H; Xiao Z; Veenstra TD; Qiu Y
    J Biol Chem; 2011 Oct; 286(41):36152-36160. PubMed ID: 21878636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.
    Wang Z; Wang Z; Guo J; Li Y; Bavarva JH; Qian C; Brahimi-Horn MC; Tan D; Liu W
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3053-8. PubMed ID: 22315407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
    Suh JH; Shong M; Choi HS; Lee K
    Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development.
    Moehren U; Papaioannou M; Reeb CA; Grasselli A; Nanni S; Asim M; Roell D; Prade I; Farsetti A; Baniahmad A
    FASEB J; 2008 Apr; 22(4):1258-67. PubMed ID: 17991730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
    Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
    Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.
    D'Antonio JM; Vander Griend DJ; Antony L; Ndikuyeze G; Dalrymple SL; Koochekpour S; Isaacs JT
    PLoS One; 2010 Jul; 5(7):e11475. PubMed ID: 20628607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
    Dehm SM; Schmidt LJ; Heemers HV; Vessella RL; Tindall DJ
    Cancer Res; 2008 Jul; 68(13):5469-77. PubMed ID: 18593950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
    Li N; Chen M; Truong S; Yan C; Buttyan R
    Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
    Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
    Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP.
    Mita P; Savas JN; Djouder N; Yates JR; Ha S; Ruoff R; Schafler ED; Nwachukwu JC; Tanese N; Cowan NJ; Zavadil J; Garabedian MJ; Logan SK
    Mol Cell Biol; 2011 Sep; 31(17):3639-52. PubMed ID: 21730289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance.
    Lim SC; Jansson PJ; Assinder SJ; Maleki S; Richardson DR; Kovacevic Z
    FASEB J; 2020 Sep; 34(9):11511-11528. PubMed ID: 32713076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.